Loading...

SGMT SAGIMET BIOSCIENCES INC Earnings Reports 8-K Filing

SGMT

SGMT

SAGIMET BIOSCIENCES INC

(SGMT)

2024 8-K

Show Summary

Show Summary

Product Expansion

Financial Statements

Financial Results

Investor Update

Investor Update

Financial Results

Financial Results

Appointment of Directors

Update of Investor Presenta...

Amendment to Press Release

Annual Meeting and Clinical...

Update Presentation

Financial Results Announcement

Appointment of CFO

Financial Results and Board...

Appointment of Interim Prin...

Financial Condition Update

Update and Positive Trial R...

Departure of CFO

Equity Grants to Executive ...

Earnings Report

Presentation Update

Update and Press Release

Earnings Reports

Update Presentation

Appointment of CFO

External Links:

Sagimet Biosciences Inc. updated information in a slide presentation and announced positive topline results from its Phase 2b clinical trial of denifanstat in NASH patients.

AI Assistant

SAGIMET BIOSCIENCES INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.